Triple-Negative Micropapillary Mucinous Breast Cancer After a Nondiagnostic Biopsy

This breast cancer diagnosis at a glance

Biomarkers
ER-negative; PR-negative; HER2-negative | triple negative
Sex
Female
Treatment
surgery

Treatment course, step by step

  1. She underwent wide local excision with partial breast reconstruction.
  2. Sentinel lymph-node biopsy was negative, and the surgical margins were clear.

What happened, in summary

A 69-year-old woman sought care for a left breast lump that had enlarged over 6 months. Examination found a large mass in the upper outer breast, while the right breast, both axillae, and systemic review were unremarkable. Despite adequate core samples, the biopsy did not establish malignancy, creating uncertainty between the clinical findings, imaging, and pathology.

Because cancer remained strongly suspected, she underwent wide local excision with partial breast reconstruction using an anterior intercostal artery perforator flap. A sentinel lymph-node biopsy was performed during the same operation.

Final pathology found a 15 mm grade II micropapillary variant of mucinous breast carcinoma. It was associated with extensive grade II intracystic papillary ductal carcinoma in situ, bringing the total affected area to 66 mm. The tumor showed micropapillary structures, hobnail cells, and psammomatous microcalcifications. It was negative for estrogen receptor, progesterone receptor, and HER2. There was no lymphovascular invasion, the surgical margins were clear, and the sentinel nodes contained no malignancy.

This rare subtype had resembled a necrotic papillary lesion on core biopsy, so the diagnosis became clear only after the full mass was removed and examined.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories